Chongqing Haifu Technology Co., Ltd. (HIFU) signed a contract with the St. Mary Hospital of Plevna City, Bulgaria, according to HIFU on October 30, 2012.
According to the contract, the hospital will apply the focused ultrasound tumor therapeutic system developed by HIFU to treat diseases such as fibroid and pancreatic cancer.
This signing marks HIFU’s new breakthrough on the international market following the entrances into the markets of Spain, Saudi Arabia and Russia.
The HIFU-developed system has been adopted by 24 medical institutions in 14 countries and regions. It has already earned recognitions from multiple renowned international medical colleges, research institutions and top-level hospitals such as the Churchill Hospital of Oxford University, the European Institute of Oncology in Italy and the Spain Hospital of Mutua De Terrassa University (HMT).